Related Experiment Video
Updated: Jun 21, 2026
Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation
Published on: February 29, 2020
Removal of displaced and impacted ASD device after 4 years
R S Dhaliwal1, H Singh, N Swami
1Department of Cardiovascular and Thoracic Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Percutaneous transcatheter closure for atrial septal defects (ASDs) offers lower morbidity but carries risks. This case highlights a rare complication requiring surgical intervention years after initial device closure due to device displacement.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Open heart surgery is the standard for atrial septal defect (ASD) closure.
- Percutaneous transcatheter closure is an alternative for simple ostium secundum ASDs, offering reduced post-procedural morbidity by avoiding sternotomy.
Observation:
- A rare complication occurred four years after percutaneous transcatheter closure of an ASD.
- The Amplatzer septal occluder device displaced from its original position.
Findings:
- Surgical removal of the displaced Amplatzer septal occluder was necessary.
- The ASD required closure via surgical intervention due to the device complication.
Implications:
- While percutaneous closure is beneficial, potential long-term complications like device displacement must be considered.
- This case underscores the need for vigilance and potential surgical management for late complications following transcatheter ASD closure.
Abstract:
Open heart surgery is the gold standard for the closure of atrial septal defects (ASDs). Percutaneous transcatheter closure is used to close simple ostium secundum ASDs. As this method avoids sternotomy, the post-procedural morbidity is lower. These procedures are associated with complications which can be life threatening and require urgent surgical intervention. We report a rare case which required surgical removal of the Amplatzer septal occluder and closure of the ASD four years after the initial percutaneous transcatheter closure due to displacement of the device.